Streamlining Viral Vector Development And Manufacturing For Gene Therapies

As clinical success, innovation, and investment in cell and gene therapy grows, emerging therapies are targeting more chronic conditions and cancers, in addition to rare diseases. This makes viral vector manufacturing—a critical component in gene and cell therapy— in demand.

Join viral vector experts to learn about MilliporeSigma's capabilities and solutions for gene therapy production and virtually tour the GMP manufacturing facility.